Presentations and Articles

Note: Some of the documents linked to this page are in Portable Document Format (PDF), and require the Adobe® Acrobat Reader for viewing. If you do not have the Acrobat Reader, visit https://get.adobe.com/reader/ to download.

NIH Technology Transfer Training
This training is mandatory for the following groups at NIH:
(NOTE: This link will only work from within NIH firewall)
  • All Principal Investigators (Senior Investigators, Investigators,
    Adjunct Investigators, Senior Scientists/Clinicians, and
    Assistant Clinical Investigators )
  • Fellows
  • Graduate Students
  • Staff Scientists/Staff Clinicians
Image:WWW

 

Guide to Federal Technology Transfer in Maryland
Maryland Department of Economic Development
2021 Jul
OSA/NCATS Workshop: Expectations and Impact of TT Image:WWW
OSA/NCATS Workshop: Innovation In and Measuring TT Image:WWW
The U.S. National Institutes of Health – Founding A National Biomedical “Innovation Ecosystem”
Steven M. Ferguson and Lynn Johnson Langer
J Commer Biotechnol. 2021 Mar; 26(1): 72–82.
Licensing the Technology: Biotechnology Commercialization Strategies Using University and Federal Labs (2nd Edition)
Steven M. Ferguson and Uma S. Kaundinya
In: Craig Shimasaki, ed. Biotechnology Entrepreneurship: Starting, Managing, and Leading Biotech Companies. (Elsevier Inc.) 2020:199-222.
I-Corps at NIH: Entrepreneurial Training Program Creating Successful Small Businesses
Christie A Canaria, Lili Portilla, Michael Weingarten
Clin Transl Sci. 2019 Jul;12(4):324-328
Intellectual Property and Technology Transfer
Bruce Goldstein
In: JI Gallin, FP Ognibene, LL Johnson, eds. Principles and Practice of Clinical Research (Fourth Edition). (Academic Press/Elsevier Inc.) 2017:447–529.
Image:WWW
A Guide to Time Lag and Time Lag Shortening Strategies in Oncology-Based Drug Development
Berna Uygur, Josh Duberman, and Steven M. Ferguson
J Commer Biotechnol. 2017 May;23(2):75-81.
Image:PDF logo
Beyond Hybrid Licenses—Strategies for Post Patent Expiration Payments in the United States
Patrick Gattari, Steven Ferguson, David Crichton, and Bryan Helwig
les Nouvelles. 2017 Mar;52(1):31-6.
Image:PDF logo
How SBIR and STTR Can Support Women in Biotech Funding for Innovation from NIH’s Small Business Programs  
Interview with Lili Portilla
In: Association for Women in Science, 2017;49:36-27
The Commercialization of New Drugs and Vaccines Discovered in Public Sector Research
Stevens, A.J., Jensen, J.J., Wyller, K., Kilgore, P.C., London, E., Zhang, Q., Chatterjee, S., and Rohrbaugh, M.L,
In: S.M. Breznitz and H. Etzkowitz, eds., Routledge, University Technology Transfer: The Globalization of Academic Innovation, 2016:102-145
NIH Inventions Translate into Drugs and Biologics with High Public Health Impact 
Sabarni K. Chatterjee and Mark L. Rohrbaugh
Nat Biotechnol. 2014 Jan 9;32(1):52-58.
Image:WWW
Collaborative Development of 2-hydroxypropyl-β-cyclodextrin for the Treatment of Niemann-Pick Type C1 Disease 
Lili Portilla 
Curr Top Med Chem. 2014;14(3):330-339
Leveraging Public Private Partnerships to Innovate Under Challenging Budget Times 
Lili Portilla and Mark L. Rohrbaugh 
Curr Top Med Chem. 2014;14(3):326-329               
If The Sky Were The Limit, What Would You Do In Technology Transfer?
Gary Keller, Fizie Haleem, Steven Ferguson, Al Jordan, and Cheryl Cejka
les Nouvelles. 2013 Mar;47(1):66-70.
Image:PDF logo
Leveraging Public Private Partnerships to Innovate Under Challenging Budget Times 
Portilla, L.M. and Rohrbaugh, M.L. 
Current Topics in Med. Chem., 2014;14(3):326-329
Intellectual Property Claims to Stem Cell Technologies: Research Clinical Testing and Product Sales
Hammersla, A.M. and Rohrbaugh, M.L.,
In: Progenitor and Stem Cell Technologies and Therapies, A. Atala, ed., Woodhead Publishing Ltd. 2012
Stem Cell Patents: What Every Researcher Should Know
Mark L. Rohrbaugh
In: Human Stem Cell Manual: A Laboratory Guide, JF Loring, SE Peterson, eds., Elsevier Press 2012;2
Partnering with the NIH: Now part of the "Value Proposition" for start-ups
Steven M. Ferguson
J Commer Biotechnol. 2012 Apr 1;18(2):60-67.
Image:PDF logo
License Compliance Issues for Biopharmaceuticals: Special Challenges for Negotiations between Companies and Non-Profit Research Institutions
Todd A. Ponzio, Hans Feindt, and Steven M. Ferguson
les Nouvelles, 2011 Sep;46(3):216-25.
Image:PubMedCentral logo
The Role of Public-Sector Research in the Discovery of Drugs and Vaccines
Ashley J. Stevens, Jonathan J. Jensen, Katrine Wyller, Patrick C. Kilgore, Sabarni Chatterjee, and Mark L. Rohrbaugh
N Engl J Med. 2011 Feb 10;364(6):535-41.
Image:WWW

 

Presentations & Articles Archive